Chronic myeloid leukemia (CML) is characterized by the presence of Philadelphia (Ph1) chromosome bearing chimeric bcr-abl gene that translates a protein p210 which has increased and unregulated tyrosine kinase activity [1]. This evidence concerns the gene EVPL and chronic myelogenous leukemia, BCR-ABL1 positive.